(PACS) PACS - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US69380Q1076
PACS: Nursing Homes, Assisted Living Facilities, Senior Care Services
PACS Group, Inc. (NYSE: PACS) operates a network of skilled nursing facilities (SNFs) and assisted living facilities (ALFs) across the United States. The company focuses on providing specialized care services, including rehabilitation, memory care, and independent living solutions tailored for seniors. Beyond operations, PACS actively engages in the acquisition, ownership, and strategic leasing of healthcare properties, integrating real estate expertise into its business model. Established in 2013 and headquartered in Farmington, Utah, PACS has carved a niche in the healthcare real estate sector, balancing operational excellence with property management.
From a financial standpoint, PACS boasts a market capitalization of over $6 billion, underscoring its significant presence in the healthcare industry. The trailing P/E ratio of 66.75 reflects a premium valuation, likely driven by growth prospects, while the forward P/E of 21.37 suggests anticipated earnings improvements. The price-to-book ratio of 11.04 indicates that investors value the companys intangible assets and future growth over its current book value. With a price-to-sales ratio of 1.78, PACS operates in a sector where revenue multiples are moderate, yet the stability of healthcare revenue streams attracts investors seeking predictable cash flows.
Navigating the evolving healthcare landscape, PACS positions itself as a key player in senior care, benefiting from demographic trends like an aging population. The companys dual focus on care services and real estate offers a diversified approach, appealing to investors and fund managers seeking exposure to both healthcare and real estate sectors. This strategic blend allows PACS to leverage the resilience of healthcare demand while capitalizing on the appreciative potential of medical properties, making it a notable entity in its space.
Additional Sources for PACS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PACS Stock Overview
Market Cap in USD | 1,437m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2024-04-11 |
PACS Stock Ratings
Growth Rating | -42.8 |
Fundamental | 41.3 |
Dividend Rating | 0.0 |
Rel. Strength | -59.5 |
Analysts | 4.5/5 |
Fair Price Momentum | 7.37 USD |
Fair Price DCF | 15.42 USD |
PACS Dividends
No Dividends PaidPACS Growth Ratios
Growth Correlation 3m | -95.8% |
Growth Correlation 12m | -65.8% |
Growth Correlation 5y | -64.1% |
CAGR 5y | -59.02% |
CAGR/Max DD 5y | -0.75 |
Sharpe Ratio 12m | -0.30 |
Alpha | -65.23 |
Beta | 0.513 |
Volatility | 48.09% |
Current Volume | 1799.7k |
Average Volume 20d | 519.2k |
As of April 19, 2025, the stock is trading at USD 9.26 with a total of 1,799,700 shares traded.
Over the past week, the price has changed by +1.09%, over one month by -22.77%, over three months by -33.67% and over the past year by -59.74%.
Partly, yes. Based on ValueRay Fundamental Analyses, PACS (NYSE:PACS) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.26 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PACS as of April 2025 is 7.37. This means that PACS is currently overvalued and has a potential downside of -20.41%.
PACS has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy PACS.
- Strong Buy: 4
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, PACS PACS will be worth about 8 in April 2026. The stock is currently trading at 9.26. This means that the stock has a potential downside of -14.04%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 35.5 | 283.4% |
Analysts Target Price | 41 | 342.8% |
ValueRay Target Price | 8 | -14% |